Psychosis-related disturbances: Psychosis, agitation and disinhibition in Alzheimer's disease: Definitions and treatment options

Geriatrics

Volumn 61, Issue 12, 2006, Pages 14-20

  Lesser, Jary M ^a,b   Hughes, Susan V ^c  

^a Department of Psychiatry ^*  (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c University of Texas Mental Sciences Institute   (United States)

Author keywords

Agitation; Alzheimer's disease; Disinhibition; Psychosis

Indexed keywords

CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; DONEPEZIL; GALANTAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; TRAZODONE; VALPROIC ACID;

AGED; AGGRESSION; AGITATION; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; BLOOD DYSCRASIA; BONE MARROW SUPPRESSION; BRADYCARDIA; BURNOUT; CAREGIVER; CLINICAL FEATURE; CLINICAL TRIAL; CONFUSION; DIABETES MELLITUS; DISINHIBITION; DRUG CHOICE; DYSLIPIDEMIA; EVALUATION; EXTRAPYRAMIDAL SYNDROME; FALLING; FRONTAL LOBE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTICE; HUMAN; HYPERACTIVITY; HYPERLIPIDEMIA; IMPULSE CONTROL DISORDER; IRRITABILITY; LOW DRUG DOSE; NAUSEA; NEUROLEPTIC MALIGNANT SYNDROME; PATIENT ABUSE; PRIMARY MEDICAL CARE; PSYCHOLOGIC TEST; PSYCHOSIS; RECOMMENDED DRUG DOSE; RESTLESSNESS; SIDE EFFECT; STOMACH IRRITATION; THROMBOCYTOPENIA; VISUAL HALLUCINATION; WEIGHT GAIN;

ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CHOLINESTERASE INHIBITORS; HUMANS; INHIBITION (PSYCHOLOGY); MENTAL DISORDERS; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS;

EID: 33845889239     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. National Institute on Aging: http://www.alzheimers.org/generalinfo.htm
2. Edell WS, Tunis SL. Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients. Amer J Geriatr Psychiatry 2001; 9(3):289-97.
3. New issues paper urges greater role for primary-care physicians and families in recognizing, diagnosing and treating Alzheimer's disease. Accessed online November 17, 2006, at http://www.prnewswire.com/cgi-bin/stories.pl?ACCT= 104&STORY=/www/story/05-08-2001/0001487782&EDATE=.
4. Finkel SI, Burns A, Cohen GD. Overview, behavioral and psychological symptoms of dementia (BPSD): A clinical and research update. Int Psychogeriatr 2000; 12(S1):13-8.
5. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment. J Clin Psychiatry 1987; 48(suppl):9-15.
6. Alexopoulos GS, Silver JM, Kahn DA, Frances A, Carpenter, D. Treatment of agitation in older persons with dementia. Postgraduate Medicine: A Special Report 1998:11-88.
7. McKeith IG, Galasko D, Kosaka K, et. al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies: Report of the consortium on DLB international workshop. Neurology 1996; 47(5):1113-24.
8. McKeith IG, Burn OJ, Ballard CG, et al. Dementia with lewy bodies. Semin Clin Neuropsychiatry 2003; 8(1):46-57.
9. Boeve, BF. Dementia with Lewy bodies. Dementia. Continuum: Lifelong Learning in Neurology 2004; 10(1):81-112.
10. Fernandez HH, Wu CK, Ott, BR. Pharmacotherapy of dementia with Lewy bodies. Expert Opin Pharmacother 2003; 4(11) 2027-37.
11. Dewey RB Jr, O'Suilleabhain PE. Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease. Neurology 2000; 55(11):1753-4.
12. Leopold NA. Risperidone treatment of drug-related psychosis in patients with parkinsonism. Mov Disord 2000; 15(2):301-4.
13. Cummings JL, Street J, Masterman D, Clark, W. Efficacy of olanzepine in the treatment of psychosis in dementia with lewy bodies. Dement Geriatr Cog Disord 2002; 13(2):67-73.
14. Tariot PN, Erb R, Leibovici A, et al. Carbamezepine treatment of agitation in nursing home patients with dementia: A preliminary study. J Am Geriatr Soc 1994; 42(11):1160-6.
15. Calkin PA, Hamilton JV, Orengo CA and Kunik ME. Trazodone for insomnia and agitation in the elderly. Clinical Geriatrics 1999; 7(7):34-39.
16. Sultzer DL et al. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatry 1997; 5:60-9.
17. Herrmann N. Valproic acid treatment of agitation in dementia. Can J Psychiatry 1998; 43(1):69-72.
18. Cohen GD. Alzheimer's disease: Managing behavioral problems in patients with progressive dementia. Geriatrics 2002; 57(2):53-4.
19. Sink KM, Holden KL, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms in dementia: A review of the evidence. JAMA 2005; 293(5):596-608.
20. Tariot PN, Raman R, Jakimovich, et al. Divalproex sodium in nursing homes residents with possible or probable Alzheimer's disease complicated by agitation: A randomized, controlled trial. Am J Geriatr Psychiatry 2005; 13(11):942-9.
21. Newcomber JW. Second generation (atypical antipsychotics and metabolic effects: A comprehensive literature review. CNS Drugs 2005; 19(Suppl 1):1-93.
22. Deberdt WG, Dysken MW, Rappaport SA, et al. Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavorial disturbances in patients with dementia. Am J Geriatr Psychiatry 2005; 13(8):722-30.
23. Brodaty H, Ames D, Snowon J, et al. A randomized placebo controlled trial of risperidone for the treatment of aggression, agitation, and psychosis in dementia. J Clin Psychiatry 2003; 64(2):134-43.
24. Rojas-Fernandez CH, Allen DA. Pharmacotherapy of behavioral and psychological symptoms of dementia: Time for a different paradigm. Pharmacotherapy 2001; 21(1):74-102.
25. Omelan C. Approach to managing behavioral disturbances in dementia. Can Fam Physician 2006; 52:191-9.